Mayne Pharma Group Buy Hold or Sell Recommendation
MAYNFDelisted Stock | USD 0.13 0.00 0.00% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Mayne Pharma Group is 'Not Rated'. Macroaxis provides Mayne Pharma buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding MAYNF positions. The advice algorithm takes into account all of Mayne Pharma's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Mayne Pharma's buy or sell advice are summarized below:
Real Value 0.12 | Hype Value 0.13 | Market Value 0.13 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Mayne Pharma Group given historical horizon and risk tolerance towards Mayne Pharma. When Macroaxis issues a 'buy' or 'sell' recommendation for Mayne Pharma Group, the advice is generated through an automated system that utilizes algorithms and statistical models.
Mayne |
Execute Mayne Pharma Buy or Sell Advice
The Mayne recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Mayne Pharma Group. Macroaxis does not own or have any residual interests in Mayne Pharma Group or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Mayne Pharma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
Not Rated
Mayne Pharma Trading Alerts and Improvement Suggestions
Mayne Pharma Group is not yet fully synchronised with the market data | |
Mayne Pharma Group has some characteristics of a very speculative penny stock | |
Mayne Pharma Group has a very high chance of going through financial distress in the upcoming years | |
The company has accumulated 413.67 M in total debt with debt to equity ratio (D/E) of 0.74, which is about average as compared to similar companies. Mayne Pharma Group has a current ratio of 0.82, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Mayne Pharma until it has trouble settling it off, either with new capital or with free cash flow. So, Mayne Pharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Mayne Pharma Group sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Mayne to invest in growth at high rates of return. When we think about Mayne Pharma's use of debt, we should always consider it together with cash and equity. | |
The entity reported the revenue of 423.92 M. Net Loss for the year was (263.34 M) with profit before overhead, payroll, taxes, and interest of 171.03 M. | |
Mayne Pharma Group has accumulated about 98.01 M in cash with (7.21 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06. | |
Roughly 23.0% of Mayne Pharma outstanding shares are owned by corporate insiders |
Mayne Pharma Returns Distribution Density
The distribution of Mayne Pharma's historical returns is an attempt to chart the uncertainty of Mayne Pharma's future price movements. The chart of the probability distribution of Mayne Pharma daily returns describes the distribution of returns around its average expected value. We use Mayne Pharma Group price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Mayne Pharma returns is essential to provide solid investment advice for Mayne Pharma.
Mean Return | -0.14 | Value At Risk | -15 | Potential Upside | 14.29 | Standard Deviation | 8.42 |
Return Density |
Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Mayne Pharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Mayne Pharma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Mayne . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Mayne Pharma Buy or Sell Advice
When is the right time to buy or sell Mayne Pharma Group? Buying financial instruments such as Mayne Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Mayne Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run SRI Sustainable Growth Thematic Idea Now
SRI Sustainable Growth
Socially responsible investments that include companies making a positive, sustainable or social impact and exclude those making a negative impact. The SRI Sustainable Growth theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize SRI Sustainable Growth Theme or any other thematic opportunities.
View All Next | Launch |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in Mayne Pink Sheet
If you are still planning to invest in Mayne Pharma Group check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mayne Pharma's history and understand the potential risks before investing.
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |